Delivery Order SPE2DB22D2206-SPE2DB25FGT03
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ML units, with a ceiling value of $9,066.12 and a firm fixed-price contract type. The delivery order is not set-aside and will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,414.08 on July 24, 2025, for the supply of Sevoflurane inhalation liquid in 250ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml units, with a ceiling value of $2,828.16. This delivery order represents a firm fixed price contract with no set-aside designation and is scheduled for ultimate completion on July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid 250ML under a firm fixed-price contract with a ceiling value of $7,802.86. The contract, awarded on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a competitively awarded procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,713.60 to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The award was made to support federal medical procurement needs, with the place of performance located in Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Sevoflurane Inhalation Liquid in 250mL quantities, with a ceiling value of $4,649.76. This firm fixed price delivery order, issued on August 28, 2025, represents a non-competitive set-aside award and is scheduled for ultimate completion by August 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $1,969.54 delivery order to AmerisourceBergen Drug Corp for 250ml of Sevoflurane inhalation liquid, with an ultimate completion date of June 25, 2025. This is a firm fixed price, non-set-aside contract executed on June 24, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sevoflurane Inhalation Liquid in 250 milliliter quantities. This competitively awarded, non-set-aside contract carries a ceiling value of $1,414.08 and utilizes firm fixed pricing, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sevoflurane Inhalation Liquid in 250ml quantities, with a ceiling value of $3,009.44. This was a firm fixed price contract awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The award represents a non-set-aside, competitively awarded procurement with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,423.80 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 1, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sevoflurane is a volatile anesthetic commonly used in surgical and medical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FGT03Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,979.33 to AmerisourceBergen Drug Corp on April 25, 2025, for the supply of Sevoflurane Inhalation Liquid in 250ml quantities. This is a firm fixed-price contract with an ultimate completion date of April 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. The award was placed to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Sevoflurane is a volatile anesthetic commonly used in surgical and medical procedures across military and federal healthcare systems. This delivery order represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a prime pharmaceutical vendor supplying a comprehensive range of medications and medical supplies to support military healthcare programs globally. The company's contract portfolio with DLA demonstrates its capacity to fulfill diverse federal medical procurement requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 4/25/25 |